Guangxi He

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 15, 2025
CLEC4G Reverses Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing PD-1 Expression via the Wnt/<i>β</i>-Catenin Pathway.

Kemin Xiao, Jin Yan, Guangxi He

Pageof 1

Frequent Collaborators